Skip to main content

Table 3 Haemodynamic status and biochemistry

From: Target renal damage: the microvascular associations of increased aortic stiffness in patients with COPD

 

Control smoker

COPD

P value

eGFR (ml/min)

67 (12)

67 (14)

0.91

UACR † (mg/mmol)

0.46 (3.24)

0.80 (3.66)

0.046

Aortic PWV (m/s)

9.9 (2.3)

10.8 (1.9)

0.051

Peripheral Systolic BP (mmHg)

150 (22)

144 (20)

0.147

Peripheral Diastolic BP (mmHg)

87 (11)

83 (11)

0.102

Peripheral Pulse pressure (mmHg)

63 (17)

60 (17)

0.497

Peripheral MAP (mmHg)

108 (13)

104 ( 12)

0.078

Heart rate (bpm)

69 (11)

77 (17)

0.014

AIx (%)

21 (6)

21 (15)

0.957

Central Pulse Pressure (mmHg)

56 (15)

54 (14)

0.65

Central MAP (mmHg)

106 (14)

104 (12)

0.67

Stroke Volume Index (ml/m 2 )

44.9 (13.9)

44.9 (10.7)

0.99

Total Cholesterol (mmol/L)

5.0 (1.2)

5.1 (1.1)

0.613

LDL-Cholesterol (mmol/L)

2.5 (1.0)

2.7 (1.0)

0.618

HDL-Cholesterol (mmol/L)

1.6 (0.4)

1.8 (0.5)

0.058

  1. All results are presented as mean (SD) unless otherwise stated.
  2. † geometric mean.
  3. Abbreviations: eGFR estimated glomerular filtration rate; UACR urinary albumin creatinine ratio; IHD ischaemic heart disease; PWV pulse wave velocity; BP blood pressure; MAP mean arterial pressure; AIx augmentation index.